Company Filing History:
2 out of 2 
2 out of 125 
1 out of 1 Years Active: 2022-2024
Title: The Innovations of Jacob Bak Holm in Gastrointestinal Health
Introduction
Jacob Bak Holm is a notable inventor based in Copenhagen, Denmark, recognized for his contributions to gastrointestinal health through innovative treatment methods. With a total of two patents to his name, his work aims to address critical health issues related to gut dysbiosis.
Latest Patents
Holm's latest patents focus on the treatment and prevention of gastrointestinal dysbiosis. The first patent describes a method for the effective treatment or prevention of gastrointestinal (GI) tract dysbiosis in a subject. This method includes the administration of a non-viable or lysate formulation. The invention further extends its application to the treatment or prevention of various diseases and conditions, such as small intestine bacterial overgrowth (SIBO), small intestine fungal overgrowth syndrome (SIFO), GI tract cancers, breast cancer, neurological disorders, malnutrition, chronic fatigue syndrome, autism, cardiovascular diseases, and GI tract infections. Holm's innovative approach underscores the significance of addressing gut health and related diseases.
Career Highlights
Jacob Bak Holm has worked with prestigious institutions, including Sykehuset Østfold HF and the University of Copenhagen. His affiliation with these institutions has provided him with a solid foundation in research and development, facilitating his contributions to the field of gastrointestinal health.
Collaborations
Throughout his career, Holm has collaborated with prominent colleagues, including Tor Lea and Charlotte Kleiveland. These partnerships have played a crucial role in advancing his research and innovations, ensuring a collaborative approach to tackling health challenges.
Conclusion
In summary, Jacob Bak Holm is a distinguished inventor whose work in gastrointestinal health is making a significant impact. His latest patents reflect innovative methods for treating various conditions related to gut dysbiosis, showcasing a commitment to improving health outcomes.